Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0002077096-25-000060
Filing Date
2025-08-25
Accepted
2025-08-25 17:15:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea0253947-defa14a_ostherap.htm DEFA14A 9689
2 GRAPHIC image_001.jpg GRAPHIC 498582
  Complete submission text file 0002077096-25-000060.txt   697561
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42195 | Film No.: 251251898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)